Quick Answer
REVELATION BIOSCIENCES, INC. reported Diluted EPS of $23.95 per share (loss) for fiscal year 2025.
REVELATION BIOSCIENCES, INC. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$23.95 | +97.7% |
| 2024 | -$1052.16 | -12366.4% |
| 2023 | -$8.44 | +94.3% |
| 2022 | -$149.20 | -251.1% |
| 2021 | -$42.50 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$1.77 | +95.6% | +74.8% |
| June 30, 2025 | -$7.01 | +97.2% | -232.2% |
| March 31, 2025 | -$2.11 | +94.6% | +94.7% |
| September 30, 2024 | -$40.15 | -303.9% | +83.7% |
| June 30, 2024 | -$246.27 | -4124.2% | -525.5% |
| March 31, 2024 | -$39.37 | -206.2% | -296.1% |
| September 30, 2023 | -$9.94 | -420.4% | -70.5% |
| June 30, 2023 | -$5.83 | -40.1% | -115.7% |
- REVELATION BIOSCIENCES, INC. showed an increase of +97.7% in Diluted EPS compared to the prior fiscal year.
- Over the 2021–2025 period, REVELATION BIOSCIENCES, INC.’s diluted eps has grown by 43.6% (from $42.50 per share (loss) to $23.95 per share (loss)).
- The most recent figure is from REVELATION BIOSCIENCES, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: